Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Flint

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Rheumatology (Oxford, England)|April 13, 2021
Prescribing anti-rheumatic drugs in pregnancy and breastfeeding-the British Society for Rheumatology guideline scopeIan Giles, Alexander Allen, Amy Crossley, et al.
European Journal of Heart Failure|December 4, 2014
Calculated plasma volume status and prognosis in chronic heart failureHua Zen Ling, Julia Flint, Morten Damgaard, et al.
Rheumatology (Oxford, England)|November 1, 2022
British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practiceKaren Schreiber, Margreta Frishman, Mark D Russell, et al.
Rheumatology (Oxford, England)|November 1, 2022
Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practiceKaren Schreiber, Margreta Frishman, Mark D Russell, et al.
Rheumatology (Oxford, England)|November 1, 2022
Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroidsMark D Russell, Mrinalini Dey, Julia Flint, et al.
Rheumatology (Oxford, England)|July 31, 2023
British Society of Rheumatology guideline working group response to European Medicines Agency safety update on HydroxychloroquineMark D Russell, Mrinalini Dey, Julia Flint, et al.
Rheumatology (Oxford, England)|November 1, 2022
British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroidsMark D Russell, Mrinalini Dey, Julia Flint, et al.
Therapeutic Advances in Musculoskeletal Disease|July 18, 2025
Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE surveyKaren Schreiber, Christine Graversgaard, Ioannis Parodis, et al.
The Lancet. Rheumatology|January 22, 2024
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseasesKaren Schreiber, Ian Giles, Nathalie Costedoat-Chalumeau, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Rheumatology (Oxford, England)|April 13, 2021
Prescribing anti-rheumatic drugs in pregnancy and breastfeeding-the British Society for Rheumatology guideline scopeIan Giles, Alexander Allen, Amy Crossley, et al.
European Journal of Heart Failure|December 4, 2014
Calculated plasma volume status and prognosis in chronic heart failureHua Zen Ling, Julia Flint, Morten Damgaard, et al.
Rheumatology (Oxford, England)|November 1, 2022
British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practiceKaren Schreiber, Margreta Frishman, Mark D Russell, et al.
Rheumatology (Oxford, England)|November 1, 2022
Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practiceKaren Schreiber, Margreta Frishman, Mark D Russell, et al.
Rheumatology (Oxford, England)|November 1, 2022
Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroidsMark D Russell, Mrinalini Dey, Julia Flint, et al.
Rheumatology (Oxford, England)|July 31, 2023
British Society of Rheumatology guideline working group response to European Medicines Agency safety update on HydroxychloroquineMark D Russell, Mrinalini Dey, Julia Flint, et al.
Rheumatology (Oxford, England)|November 1, 2022
British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroidsMark D Russell, Mrinalini Dey, Julia Flint, et al.
Therapeutic Advances in Musculoskeletal Disease|July 18, 2025
Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE surveyKaren Schreiber, Christine Graversgaard, Ioannis Parodis, et al.
The Lancet. Rheumatology|January 22, 2024
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseasesKaren Schreiber, Ian Giles, Nathalie Costedoat-Chalumeau, et al.
Pageof 3